Paul Burgman Selected Research

1- (2- nitro- 1- imidazoyl)- 3- (2,2,2- trifluoroethoxy)- 2- propanol

6/2007

In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Burgman Research Topics

Disease

8	Hypoxia (Hypoxemia) 07/2012 - 11/2004
6	Neoplasms (Cancer) 07/2012 - 11/2004
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 09/2011
1	Colorectal Neoplasms (Colorectal Cancer) 01/2007

Drug/Important Bio-Agent (IBA)

3	Oxygen (Dioxygen)IBA 09/2011 - 06/2007
2	copper (II) diacetyl- di(N(4)- methylthiosemicarbazone)IBA 08/2005 - 04/2005
2	fluoromisonidazoleIBA 04/2005 - 11/2004
1	1-dodecylpyridoxal (PLD)IBA 07/2012
1	Annexin A2 (Annexin II)IBA 09/2011
1	FibrinIBA 09/2011
1	1- (6- deoxy- 6- iodogalactopyranosyl)- 2- nitroimidazoleIBA 07/2009
1	A-factor (Streptomyces)IBA 07/2009
1	Biological ProductsIBA 07/2009
1	IodineIBA 07/2009
1	NitroimidazolesIBA 06/2007
1	imidazoleIBA 06/2007
1	1- (2- nitro- 1- imidazoyl)- 3- (2,2,2- trifluoroethoxy)- 2- propanolIBA 06/2007
1	Ethanol (Ethyl Alcohol)IBA 06/2007
1	carbogenIBA 01/2007
1	pimonidazoleIBA 01/2007
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2007
1	Proteins (Proteins, Gene)FDA Link 01/2007
1	Phosphotransferases (Kinase)IBA 11/2004
1	enhanced green fluorescent proteinIBA 11/2004

Therapy/Procedure

2	Therapeutics 07/2012 - 06/2007
1	Drug Therapy (Chemotherapy) 11/2004
1	Radiotherapy 11/2004